Breakthrough drug nearly doubles survival with advanced pancreatic cancer – an oncologist explains how daraxonrasib overcame an ‘undruggable’ disease

2026

View at publisher
Authors: Christopher Lieu
DOI: 10.64628/aai.yr459rqxr
Cited by: 1
References: 5

Fields of Study & Subjects

Pancreatic and Hepatic Oncology Research Lung Cancer Treatments and Mutations Fibroblast Growth Factor Research

Publication details

Publisher
The Conversation Media Group Ltd
Publication date
2 June 2026